These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22670305)

  • 1. Oral anticoagulants for atrial fibrillation: Which one to choose?
    Ribowsky JH; Ismael AG
    Adv NPs PAs; 2012 May; 3(5):31-2. PubMed ID: 22670305
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation.
    Kansal AR; Zheng Y; Pokora T; Sorensen SV
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):225-37. PubMed ID: 23953910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation--not so NICE in Ireland!
    Collins DR; Coughlan T
    Ir Med J; 2012; 105(7):229-31. PubMed ID: 23008880
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrial fibrillation - new frontiers in anticoagulation.
    Thomas R; Page PL; Mitchell AR
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):45-9. PubMed ID: 25088125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran versus warfarin in patients with atrial fibrillation.
    Barry M
    N Engl J Med; 2009 Dec; 361(27):2674; author reply 2675. PubMed ID: 20050385
    [No Abstract]   [Full Text] [Related]  

  • 6. Transitions of care in anticoagulation management for patients with atrial fibrillation.
    Deitelzweig SB
    Hosp Pract (1995); 2012 Oct; 40(4):20-7. PubMed ID: 23299032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New directions in anticoagulation.
    Alpert JS
    Am J Med; 2012 Mar; 125(3):217-8. PubMed ID: 22340912
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation with {blacktriangledown}dabigatran or{blacktriangledown}rivaroxaban.
    Drug Ther Bull; 2009 Oct; 47(10):116-20. PubMed ID: 19809086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.
    Siddiqui FM; Qureshi AI
    Expert Opin Pharmacother; 2010 Jun; 11(8):1403-11. PubMed ID: 20446854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New oral anticoagulants: prospects].
    Fiessinger JN
    Rev Prat; 2010 May; 60(5):613-6. PubMed ID: 20564841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness.
    Kansal AR; Sharma M; Bradley-Kennedy C; Clemens A; Monz BU; Peng S; Roskell N; Sorensen SV
    Thromb Haemost; 2012 Oct; 108(4):672-82. PubMed ID: 22898892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
    Ahrens I; Lip GY; Peter K
    Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
    [No Abstract]   [Full Text] [Related]  

  • 14. A new era for anticoagulation in atrial fibrillation.
    Mega JL
    N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
    Contractor T; Levin V; Martinez MW; Marchlinski FE
    Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.
    Lee S; Anglade MW; Pham D; Pisacane R; Kluger J; Coleman CI
    Am J Cardiol; 2012 Sep; 110(6):845-51. PubMed ID: 22651881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel anticoagulants for stroke prevention in atrial fibrillation].
    Baumhäkel M; Schirmer SH; Böhm M
    Dtsch Med Wochenschr; 2010 Nov; 135(46):2304-8. PubMed ID: 21064013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drug in atrial fibrillation--how does it function in regular health care?].
    Holmström M; Johnsson H; Lärfars G; Malmström R; Hjemdahl P
    Lakartidningen; 2009 Nov 4-12; 106(45):3019-20. PubMed ID: 19998831
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atrial fibrillation: what the GP needs to know].
    Diener HC; Kaeufer T; Bode C
    MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.